Elena Masselli: Can Statins Enhance Peginterferon Therapy in MPNs?
Elena Masselli, Full Professor of Human Anatomy at the University of Parma and Consultant Hematologist at the University Hospital of Parma, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Advances, adding:
“Thrilled to share our commentary recently published in Blood Advances on the paper by Professor Hans Hasselbalch’s group exploring the clinically relevant synergy between peginterferon and statins in patients with myeloproliferative neoplasms.
Our article discusses the signalling pathways that may contribute to the synergistic effects of these treatments.
We are truly honoured to have received such positive feedback from the authors!
Take a look and let us know your thoughts!”
Title: Are statins interferon’s best friend? Mechanistic insights
Authors: Giacomo Maria Cerreto, Cecilia Carubbi, Marco Vitale, Elena Masselli
Stay updated with Hemostasis Today.
-
Sep 11, 2026, 03:10Chris Oung: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
-
Sep 10, 2026, 21:33J. Meireles-Brandao: Lp(a)HORIZON and the Role of Inflammation in ASCVD
-
Sep 10, 2026, 21:31Alejandro González Veliz: Pregnancy is a Cardiovascular Stress Test
-
Sep 10, 2026, 21:30Tareq Abadl: Did You Know That the Type of Hemoglobin in Our Blood Changes Throughout Life?
-
Sep 10, 2026, 21:30Sumyea Kabir: Apheresis Awareness Day – One Donor, One Procedure, One Therapeutic Difference
-
Sep 10, 2026, 21:30Suhasini Sil: Excited to Share Our New Publication on HLA Beyond Histocompatibility
-
Sep 10, 2026, 21:29Michael Meneghini: Your Calves Are Not Just for Walking
-
Sep 10, 2026, 21:27One month until International Plasma Awareness Week – PPTA Europe
-
Sep 10, 2026, 21:26John Strouse: Supporting Research to Improve Lives in Sickle Cell Disease